Novo Nordisk said on Friday its experimental cardiovascular drug failed to show benefit in a late-s...
Novo drug trial fail deals setback to bid to expand beyond obesity
Novo Nordisk said on Friday its experimental cardiovascular drug failed to show benefit in a late-stage study, dealing a blow to the Danish drugmaker's...
Author: Reuters
Read Original Article